Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BAFIERTAM safely and effectively. See full prescribing information for BAFIERTAM. BAFIERTAM® (monomethyl fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
BAFIERTAM is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- monomethyl fumarate
- product_names
- monomethyl fumarate
- ndc
- 69387-001, 69387-001-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en